Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT GINKGO BIOWORKS HOLDINGS, INC.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)
Listen to this Section


$8.19
-0.8600 ( -9.50% ) 958.2K

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Market Data


Open $8.19
Previous Close $9.05
Volume 958.2K
Market Cap $570.28M
Day Range $8.07 - $9.15
52 Week Range $5.37 - $17.58
Shares Outstanding 65.32M
Change % -9.50%
Net Change ▼ -0.8600
Insider Ownership -0.04%
Exchange NYSE
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -23,559,593.00

Date Type Amount Purchased Purchaser
2024-05-06 Sale -65450.00 Dmytruk Mark E.
2024-04-29 Sale -5000000.00 Kelly Jason R
2024-04-29 Sale -5000000.00 Canton Barry
2024-04-29 Sale -5000000.00 Shetty Reshma P.
2024-04-04 Sale -65448.00 Dmytruk Mark E.
2024-03-08 Sale -1100000.00 Dmytruk Mark E.
2024-03-08 Sale -300000.00 Coen Steven P.
2024-03-06 Sale -65451.00 Dmytruk Mark E.
2024-02-06 Sale -65448.00 Dmytruk Mark E.
2024-01-05 Sale -65284.00 Dmytruk Mark E.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 97 Nov 06, 2025
8-k 8K-related 14 Nov 06, 2025
4 Insider transactions 1 Oct 21, 2025
4 Insider transactions 1 Oct 03, 2025
4 Insider transactions 1 Sep 10, 2025
8-k 8K-related 15 Sep 04, 2025
8-k 8K-related 12 Aug 29, 2025
4 Insider transactions 1 Aug 26, 2025
10-q Quarterly Reports 90 Aug 07, 2025
8-k 8K-related 14 Aug 07, 2025

Latest News


× Before browsing our site, please accept our cookies policy